12-94581934-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020698.4(TMCC3):c.683A>T(p.Glu228Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,116 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020698.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMCC3 | NM_020698.4 | c.683A>T | p.Glu228Val | missense_variant | 2/4 | ENST00000261226.9 | NP_065749.3 | |
TMCC3 | NM_001301036.2 | c.590A>T | p.Glu197Val | missense_variant | 2/4 | NP_001287965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMCC3 | ENST00000261226.9 | c.683A>T | p.Glu228Val | missense_variant | 2/4 | 1 | NM_020698.4 | ENSP00000261226.4 | ||
TMCC3 | ENST00000551457.1 | c.590A>T | p.Glu197Val | missense_variant | 2/4 | 1 | ENSP00000449888.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251410Hom.: 1 AF XY: 0.0000810 AC XY: 11AN XY: 135884
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461892Hom.: 1 Cov.: 29 AF XY: 0.0000619 AC XY: 45AN XY: 727248
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2024 | The c.683A>T (p.E228V) alteration is located in exon 2 (coding exon 2) of the TMCC3 gene. This alteration results from a A to T substitution at nucleotide position 683, causing the glutamic acid (E) at amino acid position 228 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at